Evidence map›Paper›PMID 41543548›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Prognostic value of baseline [68Ga]Ga‑DOTA‑NOC PET/CT in paediatric neuroblastoma.

Qinfeng Xu, Yueran Chen, Jieping Song, Wanhua Guo, Guoqiang Shao

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Qinfeng XuDepartment of Nuclear Medicine, The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.ORCID 0000-0002-2873-3172
Yueran ChenDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Jieping SongDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Wanhua GuoDepartment of Nuclear Medicine, Nanjing Tongren Hospital, School of Medicine, Southeast University, Nanjing, China. wanhuaguo@163.com.
Guoqiang ShaoDepartment of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. guoqiangshao@163.com.ORCID 0000-0002-3277-6933

Funding

Medical Science and Technology Development Foundation, Nanjing Municipality Health Bureau YKK21254Nanjing Medical Science and Technology Development Foundation ZKX23036National Natural Science Foundation of China 92461308
6 · The paper itself

Abstract

purposeTo evaluate the prognostic value of baseline [

methodsSixty‑five newly diagnosed patients underwent baseline [

resultsOver a median 30‑month follow‑up (range 10-51), 20 progressed and 11 died. High‑risk cases (n = 38) had higher uptake and volumes than non high‑risk (n = 27): primary‑tumour and whole‑body SUVmax (p = 0.006 and 0.001); primary‑tumour SUVpeak (p = 0.013); whole‑body TL‑NOC(p = 0.001) and GTV (p = 0.016). On multivariable Cox analysis, primary‑tumour SUVmax (HR = 1.07, 95% CI: 1.02-1.12, P = 0.005) and SUVpeak (HR = 1.06, 95% CI: 1.01-1.11, P = 0.025), as well as whole‑body TL‑NOC (per 100 SUV × cm

conclusionParameters derived from [

Indexed as

NeuroblastomaOrganometallic CompoundsPositron Emission Tomography Computed TomographyAdolescentChildChild, PreschoolFemaleHumansInfantMalePrognosisRetrospective Studies68Ga-DOTANOCOrganometallic CompoundsBaseline imagingPaediatric neuroblastomaPrognosisSomatostatin receptors (SSTRs)Volumetric PET parameters

Identifiers

PMID41543548

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.